The Cost-effectiveness of Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India

BACKGROUND: The human immunodeficiency virus (HIV) epidemic in India is concentrated among 3.1 million men who have sex with men (MSM) and 1.1 million people who inject drugs (PWID), with a mean incidence of 0.9–1.4 per 100 person-years. We examined the cost-effectiveness of both preexposure prophyl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Infect Dis
Autores principales: Kazemian, Pooyan, Costantini, Sydney, Kumarasamy, Nagalingeswaran, Paltiel, A David, Mayer, Kenneth H, Chandhiok, Nomita, Walensky, Rochelle P, Freedberg, Kenneth A
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Articles and Commentaries
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7319272/
https://ncbi.nlm.nih.gov/pubmed/30921454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz249
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares